Publications

5539 Results

Novel FLT3 point mutations within exon 14 found in patients with acute myeloid leukemia

Authors
DL Stirewalt;S Meshinchi;SJ Kussick;KM Sheets;E Pogosova-Agadjanyan;CL Willman;JP Radich
Journal / Conference
British Journal of Haematology 124:481-484
Year
2004
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9031

Adjuvant therapy of osteosarcoma, a phase II trial Southwest Oncology Group study 9139

Authors
MM Zalupski;C Rankin;JR Ryan;DR Lucas;J Muler;KS Lanier;GT Budd;JS Biermann;FJ Meyers;K Antman
Journal / Conference
Cancer 100(4):818-825
Year
2004
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-9139

A phase II pilot study of high-dose 24-hour continuous infusion of 5-FU and leucovorin and low-dose PALA for patients with colorectal cancer: A Southwest Oncology Group study

Authors
RP Whitehead;JK Benedetti;JL Abbruzzese;B Ardalan;S Williamson;ER Gaynor;SP Balcerzak;JS Macdonald
Journal / Conference
Investigational New Drugs 22:467-473
Year
2004
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9107

Recombinant human erythropoietin as an adjunct to radiation therapy and cisplatin for stage IIB-IVA carcinoma of the cervix: a Southwest Oncology Group study

Authors
RS Lavey;PY Liu;BE Greer;WR Robinson;PC Chang;RB Wynn;ME Conrad;C Jiang;M Markman;DS Alberts
Journal / Conference
Gynecologic Oncology 95:145-151
Year
2004
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9318, SWOG-9405

Long-term follow-up of a phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer in the Southwest Oncology Group

Authors
DS Alberts;C Jiang;PY Liu;SP Wilcynski;M Markman;ML Rothenberg
Journal / Conference
International Journal of Gynecologic Cancer 14:224-228
Year
2004
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9326

Loss of MHC class II gene and protein expression in diffuse large B cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the leukemia and lymphoma molecular profiling project

Authors
L Rimsza;RA Roberts;TP MIller;JM Unger;M LeBlanc;R Braziel;DD Weisenburger;WC Chan;K Muller-Hermelink;ES Jaffe;RD Gascoyne;E Campo;D Fuchs;CM Spier;RI FIsher;J Delabie;A Rosenwald;LM Staudt;T Grogan
Journal / Conference
Blood 103(11):4251-4258
Year
2004
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

A Southwest Oncology Group randomized phase II study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer

Authors
GH Lyman;SJ Green;PM Ravdin;CE Geyer Jr;CA Russell;SP Balcerzak;GT Budd;S Martino
Journal / Conference
Breast Cancer Research and Treatment 85:143-150
Year
2004
Research Committee(s)
Breast
Study Number(s)
SWOG-9520

Phase II trial of cisplatin/etoposide and concurrent radiotherapy followed by paclitaxel/carboplatin consolidation for limited small-cell lung cancer: Southwest Oncology Group 9713

Authors
MJ Edelman;K Chansky;LE Gaspar;B Leigh;GR Weiss;SA Taylor;J Crowley;R Livingston;DR Gandara
Journal / Conference
Journal of Clinical Oncology 22(1):127-132
Year
2004
Research Committee(s)
Lung
Study Number(s)
S9713

Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxel

Authors
MJ Edelman;JI Clark;K Chansky;K Albain;N Bhoopalam;GR Weiss;JK Giguere;K Kelly;J Crowley;DR Gandara
Journal / Conference
Clinical Cancer Research 10:5022-5026
Year
2004
Research Committee(s)
Lung
Study Number(s)
S9806

Magnitude of response with myeloma frontline therapy does not predict outcome: importance of time to progression in Southwest Oncology Group chemotherapy trials

Authors
BGM Durie;J Jacobson;B Barlogie;J Crowley
Journal / Conference
Journal of Clinical Oncology 22(10):1857-1863
Year
2004
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8229/30, SWOG-8624, SWOG-9028, SWOG-9210